215 related articles for article (PubMed ID: 37378783)
61. The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563673
[TBL] [Abstract][Full Text] [Related]
62. LXW7 attenuates inflammation via suppressing Akt/nuclear factor kappa B and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated BV2 microglial cells.
Peng S; Jia J; Sun J; Xie Q; Zhang X; Deng Y; Yi L
Int Immunopharmacol; 2019 Dec; 77():105963. PubMed ID: 31732449
[TBL] [Abstract][Full Text] [Related]
63.
Zeng Z; Zhang H; Gui G; Luo J; Liu S
Can J Vet Res; 2022 Oct; 86(4):254-260. PubMed ID: 36211213
[TBL] [Abstract][Full Text] [Related]
64. The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection.
Lu LW; Gao Y; Quek SY; Foster M; Eason CT; Liu M; Wang M; Chen JH; Chen F
Biomed Pharmacother; 2022 Oct; 154():113625. PubMed ID: 36058151
[TBL] [Abstract][Full Text] [Related]
65. LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC.
Thomas G; Frederick E; Thompson L; Bar-Or R; Mulugeta Y; Hausburg M; Roshon M; Mains C; Bar-Or D
J Transl Med; 2020 Nov; 18(1):452. PubMed ID: 33256749
[TBL] [Abstract][Full Text] [Related]
66. PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy.
Fattahi S; Khalifehzadeh-Esfahani Z; Mohammad-Rezaei M; Mafi S; Jafarinia M
Immunol Res; 2022 Jun; 70(3):269-275. PubMed ID: 35107743
[TBL] [Abstract][Full Text] [Related]
67. Severe COVID-19-A Review of Suggested Mechanisms Based on the Role of Extracellular Matrix Stiffness.
Kerch G
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674700
[TBL] [Abstract][Full Text] [Related]
68. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
69. Standardized Extract of
Shirato K; Takanari J; Kizaki T
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684771
[TBL] [Abstract][Full Text] [Related]
70. Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein.
Segura-Villalobos D; Roa-Velázquez D; Zavala-Vargas DI; Filisola-Villaseñor JG; Castillo Arellano JI; Morales Ríos E; Reyes-Chilpa R; González-Espinosa C
Pharmacol Rep; 2022 Dec; 74(6):1315-1325. PubMed ID: 35930194
[TBL] [Abstract][Full Text] [Related]
71. Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis.
Rajawat J; Chandra A
Curr Drug Targets; 2021; 22(13):1477-1484. PubMed ID: 33494667
[TBL] [Abstract][Full Text] [Related]
72. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
73. Fluvastatin: a choice for COVID-19 associated mucormycosis management.
Tavakkoli A; Johnston TP; Sahebkar A
Curr Med Chem; 2023 Jul; ():. PubMed ID: 37415368
[TBL] [Abstract][Full Text] [Related]
74. Statins and SARS-CoV-2 disease: Current concepts and possible benefits.
Minz MM; Bansal M; Kasliwal RR
Diabetes Metab Syndr; 2020; 14(6):2063-2067. PubMed ID: 33120281
[TBL] [Abstract][Full Text] [Related]
75. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
Yarmohammadi A; Yarmohammadi M; Fakhri S; Khan H
Eur J Pharmacol; 2021 Jan; 890():173620. PubMed ID: 33038418
[TBL] [Abstract][Full Text] [Related]
76. COVID-19: Direct and Indirect Mechanisms of Statins.
Pawlos A; Niedzielski M; Gorzelak-Pabiś P; Broncel M; Woźniak E
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920709
[TBL] [Abstract][Full Text] [Related]
77. The Potential Impact of Statins in the Treatment of Patients with COVID-19 Infection.
Esfehani RJ; Vojdanparast M; Soleimanpour S; Ferns GA; Avan A
Adv Exp Med Biol; 2021; 1352():149-158. PubMed ID: 35132599
[TBL] [Abstract][Full Text] [Related]
78. Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.
Elizagaray ML; Mazitelli I; Pontoriero A; Baumeister E; Docena G; Raimondi C; Correger E; Rumbo M
Biomed J; 2023 Feb; 46(1):81-92. PubMed ID: 35948250
[TBL] [Abstract][Full Text] [Related]
79. Statins: Beneficial Effects in Treatment of COVID-19.
Lashgari NA; Roudsari NM; Shamsnia H; Shayan M; Momtaz S; Abdolghaffari AH; Matbou Riahi M; Jamialahmadi T; Guest PC; Reiner Ž; Sahebkar A
Adv Exp Med Biol; 2023; 1412():457-476. PubMed ID: 37378783
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
